ACM
LFCR icon

Ativo Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Ativo Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-31,970
Closed -$387K – 201
2013
Q4 		$387K Buy
31,970
+3,994
+14% +$47.7K 0.17% 153
2013
Q3 		$341K Sell
27,976
-1,300
-4% -$18.1K 0.16% 157
2013
Q2 		$387K Buy
+29,276
New +$405K 0.2% 103

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ativo Capital Management's LFCR Position: Q1 2014 in Review

Ativo Capital Management sold out of Lifecore Biomedical (LFCR) in Q1 2014, closing a stake of 31,970 shares — an estimated $387K sold.

Ativo Capital Management first reported a position in LFCR in Q2 2013 and held it in 3 quarters. The position peaked at $387K in Q4 2013. 98 funds tracked by Wall St. Rank hold LFCR as of Q1 2014.

  • Ativo Capital Management reported no remaining Lifecore Biomedical position as of Q1 2014 after selling out during the quarter.
  • Ativo Capital Management sold 31,970 Lifecore Biomedical shares in Q1 2014, an estimated $387K.
  • Ativo Capital Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 3 quarters.
  • Ativo Capital Management's Lifecore Biomedical position peaked at $387K in Q4 2013.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2014.

Based on Ativo Capital Management's 13F filing for Q1 2014, filed 15 May 2014.